RENALYTIX PLC's ticker is RNLX and the CUSIP is 75973T101. A total of 24 filers reported holding RENALYTIX PLC in Q4 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,619,014 | -46.1% | 1,011,884 | -1.5% | 0.02% | -39.0% |
| Q2 2023 | $3,001,017 | +26.4% | 1,027,746 | +4.8% | 0.04% | +5.1% |
| Q1 2023 | $2,373,864 | +25.8% | 980,936 | -2.8% | 0.04% | +11.4% |
| Q4 2022 | $1,886,984 | +24.3% | 1,009,083 | -14.9% | 0.04% | +34.6% |
| Q3 2022 | $1,518,000 | -60.2% | 1,185,863 | -23.9% | 0.03% | -61.8% |
| Q2 2022 | $3,818,000 | -80.5% | 1,558,284 | -44.8% | 0.07% | -62.4% |
| Q1 2022 | $19,533,000 | -60.1% | 2,822,709 | -8.3% | 0.18% | -35.1% |
| Q4 2021 | $48,936,000 | -24.4% | 3,077,726 | -4.6% | 0.28% | -16.7% |
| Q3 2021 | $64,690,000 | -35.8% | 3,226,412 | -1.2% | 0.34% | -32.3% |
| Q2 2021 | $100,820,000 | +30.0% | 3,267,018 | +8.1% | 0.50% | +18.4% |
| Q1 2021 | $77,527,000 | +90.0% | 3,021,317 | +18.4% | 0.42% | +105.9% |
| Q4 2020 | $40,812,000 | +33.9% | 2,550,740 | +2.0% | 0.20% | +8.0% |
| Q3 2020 | $30,469,000 | – | 2,499,532 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 833,489 | $21,387,000 | 9.78% |
| Asymmetry Capital Management, L.P. | 160,969 | $4,130,000 | 2.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 134,555 | $3,453,000 | 1.88% |
| SCHOLTZ & COMPANY, LLC | 85,045 | $2,182,000 | 0.83% |
| Parian Global Management LP | 60,000 | $1,540,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 3,021,317 | $77,527,000 | 0.42% |
| Manatuck Hill Partners, LLC | 43,000 | $1,103,000 | 0.37% |
| Soleus Capital Management, L.P. | 80,000 | $2,053,000 | 0.37% |
| GOFEN & GLOSSBERG LLC /IL/ | 154,624 | $3,968,000 | 0.10% |
| Atom Investors LP | 18,335 | $470,000 | 0.08% |